Gene therapy reverses Fragile X deficits in mice
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2026 01:16 ET (29-Oct-2026 05:16 GMT/UTC)
A gene therapy designed to replace a missing brain protein restored normal brain activity and improved behavior in a mouse model of Fragile X syndrome (FXS), according to a University of California, Riverside-led study.
New research links childhood adversity to mitochondrial bioenergetic changes later in life, underscoring the impact of stress in early life on cellular health. The study also found that different types of childhood stressors leave unique biological signatures. The findings in Biological Psychiatry, published by Elsevier, add to our understanding of how early-life adversity can impact mental and physical health across the lifespan, informing screening and intervention efforts.